scPharmaceuticals to Announce Second Quarter 2024 Financial Results on Wednesday, August 14, 2024

Rhea-AI Summary

scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on optimizing infused therapy delivery, will announce its second quarter 2024 financial results on Wednesday, August 14, 2024. The company's management will host a conference call and audio webcast at 4:30 p.m. ET to discuss the financial results and provide a business update.

Participants can join the call by dialing 1-877-407-9208 (domestic) or 1-201-493-6784 (international) with the conference code 13747259. A new Call me™ feature is available to avoid operator wait times. The live webcast and replay can be accessed through the company's website under the Investor Relations section.

Management to host conference call and webcast at 4:30 p.m. ET

BURLINGTON, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that scPharmaceuticals management will host a conference call and audio webcast at 4:30 p.m. ET on Wednesday, August 14, 2024, to discuss the financial results for the second quarter 2024 and provide a business update.

Participants should dial 1-877-407-9208 (domestic) or 1-201-493-6784 (international) with the conference code 13747259.

To access the new Call me™ feature, which avoids having to wait for an operator, click here.

The live webcast and replay of the conference call can be accessed here or under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com.

About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.

Katherine Miranda
scPharmaceuticals Inc., 781-301-6869
kmiranda@scpharma.com

Investors:
PJ Kelleher
LifeSci Advisors, 617-430-7579
pkelleher@lifesciadvisors.com

FAQ

When will scPharmaceuticals (SCPH) release its Q2 2024 financial results?

scPharmaceuticals (SCPH) will release its second quarter 2024 financial results on Wednesday, August 14, 2024.

What time is scPharmaceuticals' (SCPH) Q2 2024 earnings call scheduled for?

scPharmaceuticals' (SCPH) Q2 2024 earnings call is scheduled for 4:30 p.m. ET on Wednesday, August 14, 2024.

How can investors access scPharmaceuticals' (SCPH) Q2 2024 earnings call?

Investors can access scPharmaceuticals' (SCPH) Q2 2024 earnings call by dialing 1-877-407-9208 (domestic) or 1-201-493-6784 (international) with the conference code 13747259, or by using the Call me™ feature or accessing the live webcast on the company's website.

Where can I find the replay of scPharmaceuticals' (SCPH) Q2 2024 earnings call?

The replay of scPharmaceuticals' (SCPH) Q2 2024 earnings call can be accessed under the 'News & Events' section in the Investor Relations part of the company's website, www.scpharmaceuticals.com.